Shares of DIAGNOS Inc. (CVE:ADK – Get Free Report) rose 20.9% on Tuesday . The stock traded as high as C$0.43 and last traded at C$0.41. Approximately 417,721 shares traded hands during mid-day trading, an increase of 376% from the average daily volume of 87,764 shares. The stock had previously closed at C$0.34.
Wall Street Analysts Forecast Growth
Separately, Ventum Cap Mkts upgraded shares of DIAGNOS to a “strong-buy” rating in a research report on Wednesday, July 17th.
View Our Latest Analysis on DIAGNOS
DIAGNOS Stock Up 11.9 %
DIAGNOS (CVE:ADK – Get Free Report) last announced its quarterly earnings data on Wednesday, July 17th. The company reported C($0.01) EPS for the quarter. The firm had revenue of C$0.04 million for the quarter. Analysts expect that DIAGNOS Inc. will post -0.02 EPS for the current year.
DIAGNOS Company Profile
DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes.
Featured Articles
- Five stocks we like better than DIAGNOS
- Consumer Staples Stocks, Explained
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- Ride Out The Recession With These Dividend Kings
- Lowe’s Stock: Hold Now, Buy it When it Dips
- 3 Ways To Invest In Coffee, Other Than Drinking It
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.